Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification

JOURNAL ARTICLE published 15 April 2018 in Clinical Cancer Research

Research funded by Institute of Health Carlos III (PI 12/02684) | FEDER (RETICC-RD12/0036/0076) | NCI (P50-CA58223)

Authors: Isabel Echavarria | Sara López-Tarruella | Antoni Picornell | Jose Ángel García-Saenz | Yolanda Jerez | Katherine Hoadley | Henry L. Gómez | Fernando Moreno | María Del Monte-Millan | Iván Márquez-Rodas | Enrique Alvarez | Rocío Ramos-Medina | Javier Gayarre | Tatiana Massarrah | Inmaculada Ocaña | María Cebollero | Hugo Fuentes | Agusti Barnadas | Ana Isabel Ballesteros | Uriel Bohn | Charles M. Perou | Miguel Martin